Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Verano Holdings Corp.

    World Rank (Jan-05-2024)
    6,633
    Market Cap (Jan-05-2024)
    1.555 Billion USD
    World Rank (Jul-30-2023)
    8,954
    Market Cap (Jul-30-2023)
    0.955 Billion USD
    World Rank (Dec-25-2022)
    8,345
    Market Cap (Dec-25-2022)
    1.003 Billion USD
    World Rank (Jan-07-2022)
    5,430
    Market Cap (Jan-07-2022)
    2.54 Billion USD
    Headquarters Country
  2. Supernus Pharmaceuticals

    World Rank (Jan-05-2024)
    6,703
    Market Cap (Jan-05-2024)
    1.522 Billion USD
    World Rank (Jul-30-2023)
    6,453
    Market Cap (Jul-30-2023)
    1.657 Billion USD
    World Rank (Dec-25-2022)
    5,403
    Market Cap (Dec-25-2022)
    2.026 Billion USD
    World Rank (Jan-07-2022)
    7,241
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    667 Million USD
    Annual Operating Income in USD
    46 Million USD
    Annual Net Income in USD
    61 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
  3. Eris Lifesciences

    World Rank (Jan-05-2024)
    6,710
    Market Cap (Jan-05-2024)
    1.518 Billion USD
    World Rank (Jul-30-2023)
    7,521
    Market Cap (Jul-30-2023)
    1.283 Billion USD
    World Rank (Dec-25-2022)
    7,956
    Market Cap (Dec-25-2022)
    1.092 Billion USD
    World Rank (Jan-07-2022)
    7,843
    Market Cap (Jan-07-2022)
    1.37 Billion USD
    Annual Revenue in USD
    166 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Eris Lifesciences is a pharmaceutical company with a generation of actionable medical evidence through initiatives such as the India Heart Study (IHS) and India Diabetes Study (IDS). The company annual revenue is 13,470 million INR and annual net income is 4,061 million INR for year ending March 2021. The headquarters is in India.
  4. Cansino Biologics

    World Rank (Jan-05-2024)
    6,715
    Market Cap (Jan-05-2024)
    1.516 Billion USD
    World Rank (Jul-30-2023)
    5,684
    Market Cap (Jul-30-2023)
    2.030 Billion USD
    World Rank (Dec-25-2022)
    3,500
    Market Cap (Dec-25-2022)
    3.702 Billion USD
    World Rank (Jan-07-2022)
    2,240
    Market Cap (Jan-07-2022)
    8.02 Billion USD
    Annual Revenue in USD
    675 Million USD
    Annual Net Income in USD
    300 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    CanSino Biologics is an Innovative Biopharmaceutical company. It is currently developing 16 vaccine candidates for 13 infectious disease areas, preventing meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. The headquarters is in China.
  5. Constellation Pharmaceuticals

    World Rank (Jan-05-2024)
    6,721
    World Rank (Jul-30-2023)
    6,721
    World Rank (Dec-25-2022)
    6,721
    World Rank (Jan-07-2022)
    6,721
    Annual Revenue in USD
    8,614 Million USD
    Annual Net Income in USD
    1,998 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.
  6. Pacira Biosciences

    World Rank (Jan-05-2024)
    6,744
    Market Cap (Jan-05-2024)
    1.506 Billion USD
    World Rank (Jul-30-2023)
    6,485
    Market Cap (Jul-30-2023)
    1.645 Billion USD
    World Rank (Dec-25-2022)
    5,773
    Market Cap (Dec-25-2022)
    1.820 Billion USD
    World Rank (Jan-07-2022)
    5,267
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    666 Million USD
    Annual Operating Income in USD
    71 Million USD
    Annual Net Income in USD
    16 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Pacira BioSciences is a Pharmaceutical company. It is the organization built on high ethical standards an unwavering commitment to patients and transparent communications and have a drive and a desire to improve the world around and make a meaningful difference in the lives of patients, families, communities and society. The headquarters is in USA.
  7. Zhejiang Jingxin Pharmaceutical

    World Rank (Jan-05-2024)
    6,802
    Market Cap (Jan-05-2024)
    1.487 Billion USD
    World Rank (Jul-30-2023)
    6,931
    Market Cap (Jul-30-2023)
    1.482 Billion USD
    World Rank (Dec-25-2022)
    6,835
    Market Cap (Dec-25-2022)
    1.400 Billion USD
    World Rank (Jan-07-2022)
    7,970
    Market Cap (Jan-07-2022)
    1.34 Billion USD
    Headquarters Country
  8. Mayinglong Pharmaceutical Group

    World Rank (Jan-05-2024)
    6,870
    Market Cap (Jan-05-2024)
    1.465 Billion USD
    World Rank (Jul-30-2023)
    6,730
    Market Cap (Jul-30-2023)
    1.552 Billion USD
    World Rank (Dec-25-2022)
    6,997
    Market Cap (Dec-25-2022)
    1.356 Billion USD
    World Rank (Jan-07-2022)
    6,580
    Market Cap (Jan-07-2022)
    1.86 Billion USD
    Headquarters Country
  9. Zhejiang Medicine

    World Rank (Jan-05-2024)
    6,872
    Market Cap (Jan-05-2024)
    1.464 Billion USD
    World Rank (Jul-30-2023)
    6,812
    Market Cap (Jul-30-2023)
    1.521 Billion USD
    World Rank (Dec-25-2022)
    6,183
    Market Cap (Dec-25-2022)
    1.638 Billion USD
    World Rank (Jan-07-2022)
    5,440
    Market Cap (Jan-07-2022)
    2.53 Billion USD
    Annual Revenue in USD
    1,328 Million USD
    Annual Net Income in USD
    152 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country

Share

Ads